Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses the problems with approaching public health issues, such as mental health and substance use disorders, with an industrialized approach to problem solving.
Watch
Technology Can Help Navigate Financial Assistance Programs in Specialty Care
December 29th 2021The goal of the financial counselor is to identify available funding for patient care in a timely manner, but the sheer number of resources and variables involved results in a long, tedious process.
Read More
Key Points for Pharmacists on the Impact of Biological, Sociological Variables on Treatment Outcomes
December 28th 2021Sarah Temkin, MD, of the Office of Research on Women’s Health at the National Institutes of Health, discusses some key points for pharmacists on the impact of biological and sociological variables on treatment outcomes.
Watch
Assessing the Potential Adoption of Psychedelic Medicine in Health Care Systems
December 28th 2021Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses whether the adoption and acknowledgement of psychedelic medicine in health care systems looks likely for the future.
Watch
Assessing the Ideal Environments in Which Psychedelic Medicines Should Be Administered
December 27th 2021Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which environments each psychedelic medicine is likely to be administered.
Watch